|
IQV | Iqvia Holdings Inc. |
| Services-Commercial Physical & Biological Research |
| Book value per $ invested | $ 0.15 |
| Leverage | 78.11% |
| Market Cap | $ 41.0B |
| PE | 32.10 |
| Dividend Yield | 0.00% |
| Profit | $ 1.3B |
| Margin | 8.02% |
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services.